Cargando…
Experience With Pre-Dialysis Administration of Tobramycin in the Outpatient Setting
Autores principales: | Tessier, Jean-François, Ouellet, Georges, Vallée, Michel, Lafrance, Jean-Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290086/ https://www.ncbi.nlm.nih.gov/pubmed/35860650 http://dx.doi.org/10.1177/20543581221112505 |
Ejemplares similares
-
Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study)
por: Giroux, Marjolaine, et al.
Publicado: (2021) -
Association of Neutrophil-to-Lymphocyte Ratio With Inflammation and Erythropoietin Resistance in Chronic Dialysis Patients
por: Pineault, Jérôme, et al.
Publicado: (2017) -
High mortality after pelvis and lower limb fractures in ESRD
por: Ouellet, Georges, et al.
Publicado: (2008) -
Magnitude of discordance between registry data and death certificate when evaluating leading causes of death in dialysis patients
por: Lafrance, Jean-Philippe, et al.
Publicado: (2013) -
Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection
por: Mantero, Marco, et al.
Publicado: (2017)